For its Moraiya formulation facility and Ahmedabad API facility (Zyfine)
Cadila Healthcare has received a Warning Letter issued by the US FDA relating to its Moraiya formulation facility and Ahmedabad API facility (Zyfine).Powered by Capital Market - Live News
